These results suggest that apoA-I attenuates cerebral amyloid angiopathy, which is not only a hallmark of Alzheimer's disease [12], but also a predictor for WMLs [35], [36]. This evidence concerns the gene APOA1 and early-onset autosomal dominant Alzheimer disease.